- Home
- MATV vs PRME Comparison
MATV vs PRME Comparison
Compare MATV & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MATV | PRME |
|---|---|---|
| Founded | 1995 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 644.7M | 601.1M |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MATV | PRME |
|---|---|---|
| Price | $12.14 | $4.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $10.00 | $9.31 |
| AVG Volume (30 Days) | 300.1K | ★ 3.9M |
| Earning Date | 11-05-2025 | 11-07-2025 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,982,500,000.00 | $5,977,000.00 |
| Revenue This Year | $2.62 | $111.80 |
| Revenue Next Year | $2.26 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.39 | ★ 647.13 |
| 52 Week Low | $4.34 | $1.11 |
| 52 Week High | $13.57 | $6.94 |
Technical Indicators
Market Signals| Indicator | MATV | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 51.96 | 52.10 |
| Support Level | $11.78 | $3.26 |
| Resistance Level | $12.26 | $4.08 |
| Average True Range (ATR) | 0.45 | 0.32 |
| MACD | -0.09 | 0.11 |
| Stochastic Oscillator | 38.32 | 79.17 |
Price Performance
Historical ComparisonAbout MATV Mativ Holdings Inc.
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments namely Filtration & advanced Materials focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging and healthcare solutions.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.